期刊文献+

头孢地嗪钠溶剂化物结晶过程自催化动力学

Autocatalytic kinetics of cefodizime sodium solvate in crystallization
下载PDF
导出
摘要 采用在线拉曼光谱在不同结晶温度和溶液初始浓度的条件下,研究了头孢地嗪钠溶剂化物结晶过程的动力学行为,从热力学和成核机理的角度分析了温度和初始浓度对动力学的影响。根据动力学曲线的特征,将头孢地嗪钠溶剂化物的结晶过程假定为'自催化'过程。针对头孢地嗪钠溶剂化物结晶过程的特殊性,修正了Prout-Tompkins模型;并通过不同温度下的动力学数据,采用多元线性回归拟合了头孢地嗪钠溶剂化物结晶过程的自催化动力学模型参数E和k。 The analysis on the crystallization of cefodizime sodium solvate shows that the conversion-time curve presents three characteristics: S-shape, the turning-point, and the turning-point corresponding to the maximum crystallization rate. Therefore, the crystallization of cefodizime sodium solvate could be assumed as an autocatalytic process, and the Prout-Tompkins model was modified according to the solubility curve in order to apply in solution crystallization. The autocatalytic kinetics of solvate crystallization was studied at different temperatures and initial concentrations. The effect of temperature was explained from two aspects, thermodynamics and nucleation mechanism. The kinetic parameters (activation energy E and pre-exponential factor k) of the autocatalytic kinetic models were estimated by multiple linear regression method.
出处 《化工学报》 EI CAS CSCD 北大核心 2013年第2期555-560,共6页 CIESC Journal
基金 国家自然科学基金项目(20836005,21176173) 天津市自然科学基金项目(10JCYBJC14200,11JCZDJC20700) 化学工程联合国家重点实验室开放课题项目(SKL-ChE-11B02)~~
关键词 头孢地嗪钠 溶剂化物 结晶 Prout—Tompkins模型 自催化动力学 cefodizime sodium solvate crystallization Prout-Tompkins model autocatalytic kinetics
  • 相关文献

参考文献18

  • 1Kelkheim W M. Process for the preparation of cefodizime sodium[P].US,5126445,1992.
  • 2李爱军,周雪琴,李巍,刘东志.头孢地嗪钠的合成研究[J].中国抗生素杂志,2005,30(6):332-335. 被引量:15
  • 3Kelkheim O J,Glashutten H W,Wiesbaden M W. Process for the preparation of cefodizime[P].US,4868295,1989.
  • 4Frankfurt am Main K H S,Holzappel B M,Frankfurt am Main J B. Crystalline disodium salts of cefodizime[P].US,4590267,1986.
  • 5Zhang X W,Yin Q X,Cui P L. Correlation of solubilities of hydrophilic pharmaceuticals versus dielectric constants of binary solvents[J].Industrial and Engineering Chemistry Research,2012,(19):6933-6938.
  • 6Cui P L,Zhang X W,Yin Q X. Evidence of hydrogenbond formation during crystallization of cefodizime sodium from induction-time measurements and in situ Raman spectroscopy[J].Industrial and Engineering Chemistry Research,2012,(42):13663-13669.
  • 7Marunaka T,Matsushima E,Minami Y. Acidic degradation of cefodizime (THR-221) and structural elucidation of the products (Ⅰ)[J].Chemical and Pharmaceutical Bulletin,1989,(02):367-372.
  • 8Matsushima E,Minami Y,Azuma R. Alkaline and neutral degradation of cefodizime (THR-221) and structural elucidation of the products (Ⅱ)[J].Chemical and Pharmaceutical Bulletin,1989,(02):513-515.
  • 9陈甘棠.化学反应工程[M]北京:化学工业出版社,200110.
  • 10郭汉贤.应用化工动力学[M]北京:化学工业出版社,200311.

二级参考文献7

  • 1Matsuima E, Minami Y, Azuma R, et al. Alkaline and neutral degradation of cefodizime (THR-221) and structural elucidation of the products [J]. Chem Pharm Bull,1989,37(2):513
  • 2Blumbach J, Durckheimer W, Ehlers E, et al. Cefodizime, an aminothiazolylcephalosporin V. Synthesis and structure-activity relationships in the cefodizime series[J]. J Antibiot (Tokyo), 1987,40 (1): 29
  • 3Scheunemann K H, Mencke B, Blumbach J, et al. Crystalline disodium salt of cefodizime [P]. US: 4590267,1985-08-28
  • 4Jaenicke O, Wagner H, Worm M. Process for the preparation of cefodizime [P]. US: 4868295,1986-12-01
  • 5Macher I, Widschwenter G. Production of cefotaxime and new sodium salts [P]. US: 5831086,1998-11-03
  • 6Takeda chemical industries Ltd. Cephalosporin compounds[P]. JP:84-53492,1984-03-28
  • 7Heymes R, Lutz A. 3-Acetoxymethyl-7-(iminoacetamido )-cephalosporanic acid derivatives [P]. US: 4196205,1980-04-01

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部